Miao Mo

3.4k citations

96 papers · 2.0k indexed · 1 hit paper · h-index 24

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
Oncology top 5%

Papers in ⓘ

Cancer Research 43
- Breast Cancer Treatment Studies 27
- Cancer-related molecular mechanisms research 9
Oncology 51
- Global Cancer Incidence and Screening 9
- Cancer Risks and Factors 9
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Screening and Detection 7

Co-authors: Ying Zheng (10 shared papers)Jiong Wu (16 shared papers)Wanghong Xu (9 shared papers)Dongming Peng (2 shared papers)Qunye He (2 shared papers)Yanfei Liu (2 shared papers)Xiheng Hu (13 shared papers)Zhenbao Liu (2 shared papers)
Journals: Oncotarget (6 papers)Cancer Management and Research (4 papers)Frontiers in Oncology (4 papers)OncoTargets and Therapy (3 papers)PLoS ONE (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Miao Mo

93 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Epidemiology and genomics of prostate cancer in Asian men 2021 · 174 citations

Peers

Countries citing papers authored by Miao Mo

Since Specialization

Citations

This map shows the geographic impact of Miao Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Mo more than expected).

Fields of papers citing papers by Miao Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miao Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Mo. The network helps show where Miao Mo may publish in the future.

Co-authors

The 25 scholars most cited alongside Miao Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miao Mo Line = papers co-authored together Miao Mo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies European Journal of Epidemiology ·Baodong Yao, Hong Fang, Wanghong Xu, Yujie Yan, Huilin Xu, Yinan Liu, Miao Mo, Hua Zhang, Yanping Zhao	2014	200
2	Epidemiology and genomics of prostate cancer in Asian men Nature Reviews Urology ·Yao Zhu, Miao Mo, Wei Yu, Junlong Wu, Jian Pan, Stephen J. Freedland, Ying Zheng, Dingwei Ye Hit paper breakdown →	2021	174
3	Tumor microenvironment responsive drug delivery systems Asian Journal of Pharmaceutical Sciences ·Qunye He, Jun Chen, Jianhua Yan, Shundong Cai, Hongjie Xiong, Yanfei Liu, Dongming Peng, Miao Mo, Zhenbao Liu	2019	165
4	Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling Cell Death and Disease ·Xingbo Long, Wei Xiong, Xiting Zeng, Lin Qi, Yi Cai, Miao Mo, Huichuan Jiang, Bisong Zhu, Zhi Chen, Yuan Li	2019	105
5	Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer Oncotarget ·Naisi Huang, Yayun Chi, Jingyan Xue, Mengying Liu, Sheng Huang, Miao Mo, Shuling Zhou, Jiong Wu	2016	90
6	Association between dietary nitrate and nitrite intake and site-specific cancer risk: evidence from observational studies Oncotarget ·Li Xie, Miao Mo, Huixun Jia, Fei Liang, Jing Yuan, Ji Zhu	2016	69
7	Interfacing DNA with nanoparticles: Surface science and its applications in biosensing International Journal of Biological Macromolecules ·Qunye He, Qing Wu, Xiangran Feng, Ziyan Liao, Wenyao Peng, Yanfei Liu, Dongming Peng, Zhenbao Liu, Miao Mo	2020	59
8	CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells PLoS ONE ·Miao Mo, Mi Zhou, Lu Wang, Lin Qi, Kehua Zhou, Long-Fei Liu, Zhi Chen, Xiong-Bing Zu	2015	49
9	Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer Radiotherapy and Oncology ·Huixun Jia, Xiaotao Shen, Yun Guan, Meimei Xu, Jia Tu, Miao Mo, Li Xie, Jing Yuan, Zhen Zhang, Sanjun Cai, Ji Zhu, Zheng‐Jiang Zhu	2018	48
10	Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results World Journal of Urology ·Junjie Zhang, Zhenyu Ou, Xiaobo Zhang, Wei He, Ruizhe Wang, Miao Mo, Lingxiao Chen, Ran Xu, Shusuan Jiang, Xiaoyan Peng, Lin Qi, Long Wang	2019	48
11	Breast cancer screening and early diagnosis in Chinese women Cancer Biology and Medicine ·Rui Ding, Yi Xiao, Miao Mo, Ying Zheng, Yi‐Zhou Jiang, Zhi‐Ming Shao	2022	42
12	Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation Life Sciences ·Bo Zhang, Peihua Liu, Yan Zhou, Zhi Chen, Yao He, Miao Mo, Guoyu Dai, Weiping Xia, Yongchao Du, Yuhang Liu, Xiang Chen	2019	38
13	Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial European Urology Oncology ·Bo Dai, Sheng Zhang, Fangning Wan, Hongkai Wang, Junyu Zhang, Qifeng Wang, Yunyi Kong, Xuejun Ma, Miao Mo, Yao Zhu, Xiaojian Qin, Guowen Lin, Dingwei Ye	2022	38
14	Surgical management of breast cancer in China Medicine ·Nai-Si Huang, Mengying Liu, J Chen, Benlong Yang, Jing-yan Xue, Chenlian Quan, Miao Mo, Guang‐Yu Liu, Zhen‐Zhou Shen, Zhi-Min Shao, Jiong Wu	2016	35
15	ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion Cell Death and Disease ·Longxiang Wu, Mengda Zhang, Lin Qi, Xiongbing Zu, Yuan Li, Longfei Liu, Minfeng Chen, Yangle Li, Wei He, Xiheng Hu, Miao Mo, Zhenyu Ou, Long Wang	2019	33
16	Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer Oncotarget ·Xiaoqing Jia, Hong Qi, Lei Li, Da‐Qiang Li, Jianwei Li, Miao Mo, Yujie Wang, Zhimin Shao, Zhenzhou Shen, Jingyi Cheng, Guang‐Yu Liu	2015	33
17	S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8⁺ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma Advanced Science ·Huihuang Li, Jinbo Chen, Zhenghao Li, Minfeng Chen, Zhenyu Ou, Miao Mo, Ruizhe Wang, Shiyu Tong, Peihua Liu, Zhiyong Cai, Chunyu Zhang, Zhi Liu, Dingshan Deng, Jinhui Liu, Chunliang Cheng, Jiao Hu, Xiongbing Zu	2023	32
18	Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer Frontiers in Cell and Developmental Biology ·Zhengtong Lv, Jianlong Wang, Xuan Wang, Miao Mo, Guyu Tang, Haozhe Xu, Jianye Wang, Yuan Li, Ming Liu	2021	29
19	PdZn/Co_SA‐NC Nanozymes with Highly Efficient SOD/CAT Activities for Treatment of Osteoarthritis via Regulating Immune Microenvironment Advanced Functional Materials ·Xin Yang, Manli Tan, Jianfeng Guo, Jianhui Xiang, Feiying Yin, Jiejia Deng, Ji Luo, Shihui Xiao, Miao Mo, Hanjie Wang, Jinmin Zhao, Li Zheng, Jian‐Wen Cheng, Jingping Zhong	2024	28
20	LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer Translational Andrology and Urology ·Chao Li, Jiao Hu, Xiheng Hu, Cheng Zhao, Miao Mo, Xiongbing Zu, Yangle Li	2021	27

About Miao Mo

Miao Mo is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (27 papers), Global Cancer Incidence and Screening (9 papers), Cancer-related molecular mechanisms research (9 papers), Breast Lesions and Carcinomas (9 papers), Cancer Risks and Factors (9 papers), Ferroptosis and cancer prognosis (8 papers), HER2/EGFR in Cancer Research (7 papers) and Colorectal Cancer Screening and Detection (7 papers). The work is most often cited by research in Cancer Research (563 citations), Oncology (526 citations), Pulmonary and Respiratory Medicine (493 citations), Molecular Biology (672 citations) and Urology (61 citations). Miao Mo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Ying Zheng, Jiong Wu, Wanghong Xu, Dongming Peng, Qunye He, Yanfei Liu, Xiheng Hu, Zhenbao Liu, Yao Zhu and Lin Qi. Their work appears in journals such as Oncotarget, Cancer Management and Research, Frontiers in Oncology, OncoTargets and Therapy and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact